General Motors extended the shutdown of Chevrolet bolt electric vehicles to the end of January next year

Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors

Europe’s reindustrialization is creating new opportunities for Chinese companies. However, the winners will not necessarily be those seeking quick acquisitions or rapid market access. The real opportunities belong to companies capable of embedding themselves into Europe’s industrial ecosystem and supporting the long-term transformation of local industries.

Unpacking China | Key Chinese Firms to Watch This Week （1/11/2026-7/11/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Chery Malaysia Signs Axle Assembly Agreement with Sapura Industrial

Chery（奇瑞）has signed a master purchase agreement with Malaysian automotive supplier Sapura Industrial for front and rear axle assembly, in a project estimated at MYR 307 million over four and a half years. Sapura announced the agreement on November 4.

How BYD Is Turning China's EV Advantages into Global Growth

In the first half of 2026, BYD earned more than half of its revenue outside China for the first time, and from January to October its overseas sales passed its full-year target of 1.5 million vehicles. The world’s largest maker of new energy vehicles built its lead at home on its own batteries and vertical integration, and is now taking that model abroad through exports and a growing network of overseas plants.

Sino Biopharm and Boehringer Ingelheim Sign Option and License Deal for Six Cancer Programs

Sino Biopharmaceutical（中国生物制药）and Boehringer Ingelheim（勃林格殷格翰）announced an option and license agreement on November 4 covering six preclinical cancer programs. Sino Biopharm will receive USD 358 million in upfront and near-term payments and may receive up to USD 7 billion in additional option, development, regulatory and commercial milestone payments.